-
Where There’s Smoke, There’s Fire?
I’m always looking for connections. How things connect, if they connect, why they connect. During a recent night out, an old friend commented on Canadian Tire’s recently announced transformation strategy. And I started to ask a few questions. How big is Canadian Tire relative to their closest competitors? How is the share price performing? What… Continue reading
-
Nubeva. The Painful Pivot
In JRR Tolkien’s masterpiece, ‘The Two Towers’, King Theoden of Rohan (played by the amazing Bernard Hill) seeks to understand the disaster that has befallen his Kingdom and the world. In one particularly poignant scene, coping with the death of his son, set upon by friends who question him, and foes who would see him… Continue reading
-
Northstar Gaming ~ A Good BET?
In his famous paper, ‘Investing in the unknown and unknowable’, Richard Zeckhauser opens by telling the famous story of David Ricardo made his fortune: David Ricardo made a fortune buying bonds from the British government four days in advance of the Battle of Waterloo. He was not a military analyst, and even if he were,… Continue reading
-
Going In Circles. The Power Of Circular Token Gaming Economies
In the world of gaming and gambling, success often follows Pareto’s Law, where a small percentage of users—typically 20% of the player base—drive 80% of the revenue. High-Value Players (HVPs) are the backbone of this principle, contributing disproportionately to a platform’s economic success through their engagement and spending. And now, in conjunction with HVPs,… Continue reading
-
Rivalry Token: Projected Market Cap and Growth Insights
Well, I’m at it again. Engaging in optimistic, fanciful blue sky thinking, at the intersection of two very interesting, evolving sectors – Decentralized Finance and Gaming. This post aims to estimate the potential market cap of the Rivalry Token within 1 year of its prospective launch (Launch date is likely within the next 3-6… Continue reading
-
The Way Of No Way
Set patterns, incapable of adaptability, of pliability, only offer a better cage. Truth is outside of all patterns ~ Bruce Lee Bruce Lee was a martial artist, actor, philosopher, and the founder of a martial art style he named ‘Jeet Kune Do’. JKD was a hybridization of Bruce’s various martial, philosophical and athletic learnings, captured in the book… Continue reading
-
2023 – The Year That Wasn’t
The DTM5 performance results are reported once annually at the end of each calendar year. The strategy commenced on May 15, 2020. Performance is tracked on a 1 year Money Weighted Basis (IRR), an Annualized Average Basis, and on a Total Return Basis. 2023 proved to be highly volatile. After a great first half of the year, and reporting an… Continue reading
-
What’s Next?
In a recent advisory board meeting, I took an assessment called the ‘six types of working genius,’ developed by Patrick M. Lencioni. This tool helps individuals and teams better understand their strengths and frustrations. For each person, it categorizes the six types of ‘genius’ into 3 areas – What they love doing in (working genius), … Continue reading
-
Nubeva: Pioneering Ransomware Decryption Solutions
Nubeva Technologies is an early-stage cybersecurity company based in San Jose, California. Nubeva is developing a novel, breakthrough end-point ransomware decryption solution that enables the interception and complete reversal of ransomware infections. The benefit and economics of Nubeva’s solution are compelling. Their software is an inexpensive, lightweight and scalable endpoint technology. By quickly intercepting,… Continue reading
-
Scouting Nubeva
Nubeva is a silicon valley based company, which is listed on the TSX Venture Exchange with the symbol NBVA. Nubeva has developed a novel, groundbreaking solution to dealing with ransomware, a massive global plague. Their technology – an endpoint software that detects and captures ransomware keys, enables fast, immediate and complete reversal of a ransomware… Continue reading
-
The Dead Man’s Hand
On August 2, 1876, James Butler Hickok, known as ‘Wild Bill Hickok’ was playing poker at Nuttal & Mann’s Saloon No. 10 in Deadwood, Dakota. Poker was a passion of Wild Bill’s. And a profession. When playing, Bill would always sit with his back to the wall, so as to be able to see who was… Continue reading
-
Another Credibility Milestone for NBVA Achieved
DTM5 blogpost newsflash! I don’t usually post about news updates, but one of my key holdings, Nubeva Technologies, keeps on delivering. Here is today’s press release in it’s entirety. Full disclosure – I hold a meaningful long position in Nubeva. I’m very pleased with the company’s progress. I think this is important news, especially in… Continue reading
-
Options on Cingulate Inc.
Cingulate is an early stage Pharma company that is commercializing a drug candidate, CTx-1301. CTx-1301 is the long established and effective drug Dexmethylphenidate, used in the treatment of attention deficit hyper activity disorder (ADHD). Cingulate has packaged dexmethylphenidate in a patented, novel pill delivery platform which controls “drug release at precise, pre-defined times with no… Continue reading
-
Proof of Concept Achieved
Its the three year anniversary of the inception of the DTM5 Strategy! The first deposit was made on May 15, 2020. I launched my blog – The DTM5 Venture Investing Strategy – later that year to journal about my progress and process. The DTM5 strategy was conceived as a way to take advantage of the… Continue reading
-
Deciphering Nubeva
The situation at Nubeva looks pretty darn good – at least as far as I can see. As things evolve, the numbers should become clearer, and the road ahead from a valuation perspective more predictable. Continue reading
-
Wisdom Of The Ronin
The year was 1612. The place was feudal Japan. Miyamoto Musashi – the esteemed yet vagabond Ronin, wanted to put an end to the notion that Sasaki Kojiro – famed samurai – was a superior swordsman. So a duel between the two was arranged. Kojiro, also known as ‘The Demon of the West’, was a… Continue reading
-
All Who Wander Are Not Lost…..
I like to wander. I find interest in many things. I like my brain to be stimulated. I like to dive deep into things, but only after a thorough ‘circling of the field’ to make sure it will be a good, enjoyable or profitable use of my time. Continue reading
-
What’s Your Position (Size)?
If you are a competent investor, position sizing is something you should consider. It is a way to organize your resources for maximum success. Read More! Continue reading
-
How Time Flies – Almost 3 Years in Review
My original intent in the strategy was to focus on a select group of investments (5) and build good size positions in them and hold them until my thesis on each played out. Things shaped up a little differently. Continue reading
-
Still at the table with Real Luck Group
Real Luck Group. They’ve made some solid progress since they turned on the marketing tap. A plan. Execution. Stability. Commitment to goals. Fiscal responsibility. This is music to my venture investor’s ears. Continue reading
-
Achieve Life Sciences, Asymmetry and Position Size
I’m building a position in Achieve Life Sciences (ACHV-NASDAQ). It is a simple thesis. They have a drug candidate, Cytisinicline, in final P3 confirmatory testing for smoking cessation. They’ve also begun P2 testing on the drug for Vaping cessation. Results from Initial P3 testing for smoking cessation are excellent. The drug demonstrated a high degree… Continue reading
-
Gaining Situational Awareness
I’m always looking at ways of improving my investing outcomes. I like to try to use different mindsets and mental processes, from outside the investing world, to keep me fresh and competent. Recently, I’ve been thinking about the way I approach research / due diligence. I’m finding the concept of ‘situational awareness’ very useful, in… Continue reading
-
Thoughts on Nubeva Technologies
Nubeva Technologies (TSXV – NBVA) has the potential to be a great company. Its success will be based on the commercialization of it’s technology – A patented, novel software that intercepts and reverses ransomeware. Continue reading
-
Reviva Pharmaceuticals – Comment
In my opinion, p2 results indicate reviva has a drug candidate that is meaningfully more effective than Karuna’s and superior in every way to Aripiprazole, the current largest selling antipsychotic in the world. Continue reading
-
DTM5 Holdings Update and Commentary
The summer is almost gone, and it has been a heck of a year so far. Most of my holdings have been beaten down along with everything else. I’ve made some serious adjustments since the start of the year. As I commented on my ‘Results & Asset Allocation’ page as of Dec 31, 2021, for… Continue reading
